SightfileU.S. market data from official filings

MEDIWOUND LTD (MDWD)

Name: MEDIWOUND LTD (MDWD) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001593984 · EDGAR filings · Updated 2026-06-04

MEDIWOUND LTD (MDWD) has reported institutional ownership of 46.9%, with 75 institutional managers holding positions valued at $97.0M per the latest 13F reporting period.

Institutional ownership

46.9%

Institutional managers

Reported 13F value

$97.0M

Latest updates

2026-06-04 — Insider transaction reported (Form 4)
2026-06-02 — Insider transaction reported (Form 4)
2026-06-01 — Insider transaction reported (Form 4)
2026-05-27 — Foreign issuer report (6-K) filed
2026-05-15 — SCHEDULE 13G filed
2026-05-06 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MEDIWOUND LTD has 75 institutional holders and institutional ownership of 46.9%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 11 reporting insiders, with a net reported value of $0.

Related companies

PEPGEN INC (PEPG) · ORCHESTRA BIOMED HLDGS INC (OBIO) · KARYOPHARM THERAPEUTICS INC (KPTI) · KORU MEDICAL SYSTEMS INC (KRMD) · FATE THERAPEUTICS INC (FATE) · PRECISION BIOSCIENCES INC (DTIL)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-04.